Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The 2007 annual report includes a copy of the Company's Form 20-F for thefiscal year ended December 31, 2007, which was filed with the U.S. Securitiesand Exchange Commission on June 16, 2008.
Advertisement
Shareholders can receive a hard copy of the annual report free of chargeby sending a request through our website or by contacting our IRrepresentatives stated below.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. For more information, please visit:http://www.wuxipharmatech.com .For more information, please contact: Investor Contact: Dr. Hai Mi, Vice President Corporate Communications WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-3726 Email: [email protected] Web: http://www.wuxipharmatech.com Investor Relations (US): Mahmoud Siddig, Director Taylor Rafferty Tel: +1-212-889-4350 Email: [email protected] Web: http://www.taylor-rafferty.com Investor Relations (HK): Ruby Yim, Managing Director Taylor Rafferty Tel: +852-3196-3712 Email: [email protected] Web: http://www.taylor-rafferty.com Media Contact: John Dudzinsky, Director Taylor Rafferty Tel: +1-212-889-4350 Email: [email protected] Web: http://www.taylor-rafferty.com
SOURCE WuXi PharmaTech (Cayman) Inc.
